NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,428 | +176.3% | 35,100 | 0.0% | 0.01% | +160.0% |
| Q2 2023 | $6,669 | +60527.3% | 35,100 | 0.0% | 0.01% | -44.4% |
| Q4 2022 | $11 | -99.9% | 35,100 | 0.0% | 0.01% | -40.0% |
| Q3 2022 | $15,000 | 0.0% | 35,100 | 0.0% | 0.02% | +15.4% |
| Q2 2022 | $15,000 | -65.9% | 35,100 | 0.0% | 0.01% | -60.6% |
| Q1 2022 | $44,000 | -4.3% | 35,100 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $46,000 | -36.1% | 35,100 | 0.0% | 0.03% | -40.4% |
| Q3 2021 | $72,000 | +30.9% | 35,100 | 0.0% | 0.06% | +35.7% |
| Q2 2021 | $55,000 | -29.5% | 35,100 | 0.0% | 0.04% | -34.4% |
| Q1 2021 | $78,000 | -12.4% | 35,100 | 0.0% | 0.06% | -17.9% |
| Q4 2020 | $89,000 | +3.5% | 35,100 | 0.0% | 0.08% | -8.2% |
| Q3 2020 | $86,000 | -31.2% | 35,100 | 0.0% | 0.08% | -34.6% |
| Q2 2020 | $125,000 | +52.4% | 35,100 | 0.0% | 0.13% | +20.4% |
| Q1 2020 | $82,000 | – | 35,100 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |